SELECTBIO is organizing its inaugural International Conference on ADC Development & Manufacture “Current Trends in Antibody Drug Conjugates” scheduled to be held on March 2-3, 2015 in Sheraton Bangalore Hotel at Brigade Gateway, Bangalore, India.
This event aims to bring together scientists working in the field of antibody drug conjugates, novel linker molecules and payloads at a platform for sharing of their knowledge and experience in this field. ADC is an innovative therapeutic application which combines the distinctive properties of monoclonal antibodies (mAbs) with the potent cytotoxic effects of small drug molecules. This conference will be covering the different aspects of ADC research, development and manufacture, right from the introduction to regulatory aspects thereby ensuring comprehensive understanding of the subject. In addition this event will provide an excellent platform for knowledge sharing, collaborative research and networking with the scientists in the field of Antibody Engineering, Antibody drug conjugates, biopharmaceuticals and Cancer research. About 50-75 scientists from India and abroad and from Industry and academics are expected to attend the conference. With experts like Dimiter Dimitrov, Head, NIH, USA, Palani Palaniappan, Takeda Pharmaceuticals and several more serving as Speakers, this event will provide an excellent platform for researchers from all facets of drug research an unprecedented opportunity to explore the advancements in the field of antibody drug conjugates.
This conference is co-located with another inaugural international conference on Cell Culture and Cell based assays “CellTech India 2015”. Participants registered for one conference can attend both the co-located conferences. For enhanced and cost-effective learning and comfortable stay SELECTBIO INDIA has recently introduced affordable conference packages for the delegates. The details of these packages are available at www.selectbiosciences.com.
The two conferences will be followed by one day post conference training course entitled “Advanced cell based Assays and Phenotypic Screening Approaches in Biomedical Research & Drug Discovery” to be conducted by Dr Anthony M Davies, Australia. This training course will also have live demos at Advanced High Content & High Throughput Screening facility at C-CAMP, Bangalore. The training course followed by live demo has been specially arranged so as to give the participants greater and lasting learning experience.